| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |